Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment.

Beckmann, Kerri; Selva-Nayagam, Sudarshan; Olver, Ian; Miller, Caroline; Buckley, Elizabeth S; Powell, Kate; Buranyi-Trevarton, Dianne; Gowda, Raghu; Roder, David; Oehler, Martin K

Beckmann, Kerri; Selva-Nayagam, Sudarshan; Olver, Ian; Miller, Caroline; Buckley, Elizabeth S; Powell, Kate; Buranyi-Trevarton, Dianne; Gowda, Raghu; Roder, David; Oehler, Martin K.

Afiliação

Beckmann K; Cancer Epidemiology and Population Health Research, University of South Australia, Adelaide, Australia.
Selva-Nayagam S; Medical Oncology, Royal Adelaide Hospital Cancer Centre, Adelaide, Australia.
Olver I; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
Miller C; South Australian Health and Medical Research Institute, Adelaide, Australia.
Buckley ES; School of Public Health, University of Adelaide, Adelaide, Australia.
Powell K; Cancer Epidemiology and Population Health Research, University of South Australia, Adelaide, Australia.
Buranyi-Trevarton D; South Australian Health and Medical Research Institute, Adelaide, Australia.
Gowda R; Central Adelaide Local Health Network, SA Health, Adelaide, Australia.
Roder D; Radiation Oncology, Royal Adelaide Hospital, Adelaide, Australia.
Oehler MK; Cancer Epidemiology and Population Health Research, University of South Australia, Adelaide, Australia.

Cancer Manag Res ; 13: 4633-4645, 2021.

Article em En | MEDLINE | ID: mdl-34140809

Palavras-chave

adjuvant chemotherapy; adjuvant radiotherapy; management; multimodal therapy; survival; uterine carcinosarcoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google